cinacalcet

This medicine is used in adults to treat secondary hyperparathyroidism (in patients with severe kidney disease requiring dialysis), to reduce high calcium levels in the blood in parathyroid cancer, and in primary hyperparathyroidism (when surgery is not possible). In children and adolescents, it is used to treat secondary hyperparathyroidism associated with severe kidney disease.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: Meditrial Internationals Ltd, S.C. Polisano Pharmaceuticals S.R.L.

This medicine is used in adults to treat secondary hyperparathyroidism (in people with severe kidney disease requiring dialysis), to reduce high blood calcium levels in parathyroid cancer, or in primary hyperparathyroidism (when surgery is not possible). In children and adolescents, it is used to treat secondary hyperparathyroidism associated with severe kidney disease.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: Meditrial Internationals Ltd, S.C. Polisano Pharmaceuticals S.R.L.

This medicine is used in adults to treat secondary hyperparathyroidism (in patients with severe kidney disease requiring dialysis), to reduce high calcium levels in the blood in parathyroid cancer, or in primary hyperparathyroidism (when surgery is not possible). In children and adolescents, it is used to treat secondary hyperparathyroidism associated with severe kidney disease.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: Meditrial Internationals Ltd, S.C. Polisano Pharmaceuticals S.R.L.

This medicine helps control the levels of parathyroid hormone (PTH), calcium, and phosphorus in the body. It is used in adults to treat secondary hyperparathyroidism (in severe kidney disease requiring dialysis), and to reduce high calcium levels in the blood in patients with parathyroid cancer or primary hyperparathyroidism (when surgery is not possible). In children, it is used to treat secondary hyperparathyroidism in severe kidney disease.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques - Lyon Generis Farmaceutica, S.A.

This medicine is used in adults to treat secondary hyperparathyroidism in patients with severe kidney disease requiring dialysis, and also to reduce elevated calcium levels in the blood in patients with parathyroid carcinoma or primary hyperparathyroidism. In children aged 3 to 18 years, it is used to treat secondary hyperparathyroidism in patients with severe kidney disease.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques - Lyon Generis Farmaceutica, S.A.

This medicine is used in adults and children (from 3 to 18 years old) to control the levels of parathyroid hormone (PTH), calcium, and phosphorus in the body. It helps in the treatment of secondary hyperparathyroidism in people with severe kidney disease requiring dialysis and in reducing elevated calcium levels in the blood in patients with parathyroid cancer or primary hyperparathyroidism.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques - Lyon Generis Farmaceutica, S.A.

This medicine is used in adults to treat secondary hyperparathyroidism in patients with severe renal disease requiring dialysis, to reduce elevated calcium levels in patients with parathyroid carcinoma or primary hyperparathyroidism (if surgery is not possible). In children and adolescents, it is used to treat secondary hyperparathyroidism associated with severe renal disease when other treatment methods are not effective.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: Devatis GmbH

This medicine is used in adults to treat secondary hyperparathyroidism in patients with severe kidney disease requiring dialysis, to reduce elevated calcium levels in patients with parathyroid carcinoma, or in primary hyperparathyroidism (when surgery is not possible). In children and adolescents, it is used to treat secondary hyperparathyroidism associated with severe kidney disease.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: Devatis GmbH

This medicine is used in adults to treat secondary hyperparathyroidism in patients with severe kidney disease requiring dialysis, and to reduce elevated calcium levels in patients with parathyroid carcinoma or primary hyperparathyroidism (if surgery is not possible). In children and adolescents, it is used to treat secondary hyperparathyroidism associated with severe kidney disease.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: Devatis GmbH

This medicine is used in adults to treat secondary hyperparathyroidism in patients with severe kidney disease requiring dialysis, as well as to reduce elevated blood calcium levels (hypercalcemia) in patients with parathyroid carcinoma or primary hyperparathyroidism. In children and adolescents, it is used to treat secondary hyperparathyroidism associated with severe kidney disease.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: Laboratorios Normon, S.A.

This medicine is used in adults to treat secondary hyperparathyroidism associated with severe kidney disease (requiring dialysis), to reduce high calcium levels in parathyroid cancer or primary hyperparathyroidism (when surgery is not possible). In children and adolescents, it is used to treat secondary hyperparathyroidism in severe kidney disease when other treatment methods are ineffective.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: Laboratorios Normon, S.A.

This medicine is used in adults to treat secondary hyperparathyroidism associated with severe kidney disease (requiring dialysis), to reduce elevated calcium levels in parathyroid carcinoma or primary hyperparathyroidism (when surgery is not possible). In children and adolescents, it is used to treat secondary hyperparathyroidism in severe kidney disease when other treatment methods are ineffective.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: Laboratorios Normon, S.A.

It is used in adults and children for the treatment of diseases related to parathyroid dysfunction, such as secondary hyperparathyroidism (e.g., in individuals with severe kidney disease requiring dialysis), and to reduce high calcium levels in the blood (hypercalcemia) in individuals with cancer or primary hyperparathyroidism.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: S.C. Zentiva S.A.

The medicine is used in adults for the treatment of secondary hyperparathyroidism (in patients with severe kidney disease requiring dialysis) and to reduce high calcium levels in the blood (hypercalcemia) in patients with parathyroid carcinoma or primary hyperparathyroidism. In children and adolescents, it is used for the treatment of secondary hyperparathyroidism associated with severe kidney disease.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: S.C. Zentiva S.A.

The medicine is used in adults and children for the treatment of diseases related to parathyroid dysfunction, such as secondary hyperparathyroidism (in patients with severe kidney disease requiring dialysis) and to reduce high calcium levels in the blood (hypercalcemia) in individuals with cancer or primary hyperparathyroidism.

Form: tablets, film-coated

ATC: H05BX01

Manufacturer: S.C. Zentiva S.A.